PPIDT00489
Drug Information
| Name | Pegcetacoplan |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB16694 |
| Type | biotech |
| Indication | Pegcetacoplan is indicated to treat adults with paroxysmal nocturnal hemoglobinuria (PNH).[L34095] It is also indicated to treat geographic atrophy (GA) secondary to age-related macular degeneration.[L45354] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Subcutaneous |
1080 mg
|
| Injection, solution | Subcutaneous |
1080 mg/20mL
|
| Solution | Subcutaneous |
1080 mg / 20 mL
|
| Injection, solution | Intravitreal |
15 mg/0.1mL
|